(HealthDay News) — Many individuals who are not up to date with recommended vaccinations would accept vaccines if offered during an emergency department visit, according to research published in the ...

The ArteraAI Prostate Test is intended to assist clinicians and patients with risk-based decisions in localized prostate cancer.

(HealthDay News) — Most individuals living in underserved communities believe that dermatologic side effects (DSEs) from anticancer therapies (ACTs) occur at high rates, according to a study published ...

GLP-1 receptor agonists linked to modestly increased risk for incident DR, but tied to reduced risk for certain complications of DR.

This is the first randomized trial to investigate metastasis-directed therapy plus continuous androgen deprivation therapy for oligometastatic prostate cancer.

Magnetic stimulation plus bladder training and TTNS plus bladder training are both more effective than bladder training alone.

The Food and Drug Administration (FDA) has approved the first generic version of Venofer ® (iron sucrose) Injection.

Observational study findings link dialysis dose reduction to worse postoperative patient survival.

Clinicians should carefully monitor manganese levels to avoid dysregulation in patients with chronic kidney disease (CKD).

Metabolic dysfunction-associated steatotic liver disease (MASLD) significantly increases the risk of developing hepatocellular carcinoma (HCC) in patients with type 2 diabetes, according to results of ...

Disability insurance applications and appeals (18.6%).

Recent reports highlight uncertainty about pharmaceutical tariffs, an error-prone AI tool in use at the FDA, and research funding in jeopardy.